Revolution Medicines, Inc. (RVMD) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures tumble as Amazon, Intel results deepen AI spending woes
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
Tweet
Share
E-mailGet Alerts RVMD Hot Sheet
Join SI Premium – FREE
Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($0.82), $0.03 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $7.02 million.
For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
- Regeneron (REGN) Tops Q3 EPS by $4.01, Beats on Revenue
- BP plc (BP) Tops Q3 EPS by 83c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
